Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis
Paediatrics
Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis
Paediatrics

Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis

Ital J Dermatol Venerol. 2024 Nov 4. doi: 10.23736/S2784-8671.24.07940-4. Online ahead of print.

NO ABSTRACT

PMID:39495495 | DOI:10.23736/S2784-8671.24.07940-4